In this episode of ATTD 2026 Conference Catch-Up, we dive into Hot from the Oven, featuring the latest advancements in diabetes care and treatments. Join us as we summarize key takeaways from these thought-provoking presentations: • Evaluation of CGM-based Insulin Dose Guidance System in People with Type 1 and Type 2 Diabetes: Single Arm Feasibility Study - Prof. Andrej Janež • FREEDM2 RCT: New Insights into CGM with Basal Insulin in T2DM - Dr. Emma G. Wilmot • Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults Initiating Treatment Early in the Course of Type 2 Diabetes: Results from SURPASS-Early Study after 2 Years of Treatment - Prof. Stefano Del Prato • The Progress Study: Phase 1/2 Clinical Trial of KRIYA-839, a Novel AAV Gene Therapy for Adults with Type 1 Diabetes - Dr. Jeremy Pettus This episode is an essential listen for healthcare professionals in endocrinology and diabetes care, looking to stay up-to-date with cutting-edge research and treatment advancements. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related